Evidence map›Paper›PMID 20427672›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2010

Type 4 phosphodiesterase plays different integrating roles in different cellular domains in pyramidal cortical neurons.

Liliana R V Castro, Nicolas Gervasi, Elvire Guiot, Laetitia Cavellini, Viacheslav O Nikolaev, Danièle Paupardin-Tritsch, Pierre Vincent

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. From transcriptomics to digital twins of organ function.Frontiers in cell and developmental biology · 2024
    Article
  3. A Role for Second Messengers in Axodendritic Neuronal Polarity.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2023
    Review
  4. Review
  5. Article
  6. Regulating cellular cyclic adenosine monophosphate: "Sources," "sinks," and now, "tunable valves".Wiley interdisciplinary reviews. Systems biology and medicine · 2020
    Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Signaling: Spatial regulation of axonal cAMP.Nature chemical biology · 2017
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Liliana R V CastroCentre National de la Recherche Scientifique, Unité Mixte de Recherche 7102, Paris, France.
Nicolas Gervasi
Elvire Guiot
Laetitia Cavellini
Viacheslav O Nikolaev
Danièle Paupardin-Tritsch
Pierre Vincent
Sorbonne Université · FRCentre National pour la Recherche Scientifique et Technique (CNRST) · MAESPCI Paris · FRUniversity of Würzburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We investigated the role of phosphodiesterases (PDEs) in the integration of cAMP signals and protein kinase A (PKA) activity following beta-adrenergic stimulation, by carrying out real-time imaging of male mouse pyramidal cortical neurons expressing biosensors to monitor cAMP levels (Epac1-camps and Epac2-camps300) or PKA activity (AKAR2). In the soma, isoproterenol (ISO) increased the PKA signal to approximately half the maximal response obtained with forskolin, with a characteristic beta(1) pharmacology and an EC(50) of 4.5 nm. This response was related to free cAMP levels in the submicromolar range. The specific type 4 PDE (PDE4) inhibitor rolipram had a very small effect alone, but strongly potentiated the PKA response to ISO. Blockers of other PDEs had no effect. PDE4 thus acts as a brake in the propagation of the beta(1)-adrenergic signal from the membrane to the bulk somatic cytosol. The results for a submembrane domain were markedly different, whether recorded with a PKA-sensitive potassium current related to the slow AHP or by two-photon imaging of small distal dendrites. The responses to ISO were stronger than in the bulk cytosol. This is consistent with the cAMP/PKA signal being strong at the membrane, as shown by electrophysiology, and favored in cellular domains with a high surface area to volume ratio, in which this signal was detected by imaging. Rolipram alone also produced a strong cAMP/PKA signal, revealing tonic cAMP production. PDE4 thus appears as a crucial integrator with different physiological implications in different subcellular domains.

Indexed as

Adenylyl CyclasesAdrenergic beta-1 Receptor AgonistsAdrenergic beta-AgonistsAnimalsCell MembraneCentral Nervous System AgentsColforsinCyclic AMPCyclic AMP-Dependent Protein KinasesCyclic Nucleotide Phosphodiesterases, Type 4DendritesIn Vitro TechniquesIsoproterenolMaleMiceMice, Inbred C57BLAdenylyl CyclasesAdrenergic beta-1 Receptor AgonistsAdrenergic beta-AgonistsCentral Nervous System AgentsColforsinCyclic AMPCyclic AMP-Dependent Protein KinasesCyclic Nucleotide Phosphodiesterases, Type 4IsoproterenolPhosphodiesterase 4 InhibitorsPhosphodiesterase InhibitorsPotassiumReceptors, Adrenergic, beta-1Rolipram

Identifiers

PMID20427672
PMCPMC6632585
OpenAlexW2032138004

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.